Literature DB >> 6988517

Purification, immunochemical, and biologic characterization of the Schistosoma circulating M antigen.

Y Carlier, D Bout, G Strecker, H Debray, A Capron.   

Abstract

Circulating M antigen, specific for genus Schistosoma, was previously described in serum, urine, patients' milk, and in serum and urine of animals infected by S. mansoni. The M antigen was thermostable and soluble in trichloroacetic acid. It was not hydrolyzed by protease, ribonuclease, amylase, or neuraminidase but destroyed by sodium metaperiodate. In the present study, we have purified the M ag by using trichloroacetic acid solubility, DEAE Sephadex, and immunoadsorption. The M ag showed a neutral electric charge, a m.w. heterogeneity, and was only stained by periodic acid-Schiff. The composition study revealed M ag was a glycoprotein with a polysaccharide moiety (63% of the molecules) particularly rich in galactose, fucose, glucosamine, and mannose, and with a high molecular ratio of serine and threonine. The presence of O-glycosidic linkage allowed M ag to be considered as a mucin or a mucus glycoprotein-like component. It was localized in the cell wall of the gut of adult worms.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988517

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Detection and quantification of circulating antigen in schistosomiasis by monoclonal antibody. II. The quantification of circulating antigens in human schistosomiasis mansoni and haematobium: relationship to intensity of infection and disease status.

Authors:  H Feldmeier; J A Nogueira-Queiroz; M A Peixoto-Queiroz; E Doehring; J P Dessaint; J E de Alencar; A A Dafalla; A Capron
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  Schistosoma mansoni: analysis of monoclonal antibodies reactive with gut-associated antigens.

Authors:  G J van Dam; D Kornelis; R J Van Zeyl; J P Rotmans; A M Deelder
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

3.  Detection and quantification of circulating antigen in schistosomiasis by a monoclonal antibody. I. Specificity analysis of a monoclonal antibody with immunodiagnostic capacity.

Authors:  J A Nogueira-Queiroz; C Lutsch; M Capron; J P Dessaint; A Capron
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

4.  Surface antigen detected by a Schistosoma mansoni monoclonal antibody in worm extracts and kidney deposits of infected mice and hamsters.

Authors:  C R Carneiro; J D Lopes
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

5.  Schistosoma mansoni: detection and characterization of schistosome derived antigens by inhibition enzyme-linked immunosorbent assay (IELISA) utilizing monoclonal antibodies.

Authors:  S K Abdel-Hafez; S M Phillips; D M Zodda
Journal:  Z Parasitenkd       Date:  1984

6.  Sera of Schistosoma japonicum-infected patients cross-react with diagnostic 31/32 kD proteins of S. mansoni.

Authors:  A Ruppel; Y E Shi; D X Wei; H J Diesfeld
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

Review 7.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

8.  Ultrastructural localization of the circulating cathodic antigen in the digestive tract of various life-cycle stages of Schistosoma mansoni.

Authors:  R de Water; J A Fransen; A M Deelder
Journal:  Z Parasitenkd       Date:  1986

9.  Immunodiagnostically applicable monoclonal antibodies to the circulating anodic antigen of Schistosoma mansoni bind to small, defined oligosaccharide epitopes.

Authors:  H J Vermeer; G J van Dam; K M Halkes; J P Kamerling; J F G Vliegenthart; C H Hokke; A M Deelder
Journal:  Parasitol Res       Date:  2003-04-15       Impact factor: 2.289

10.  Granulocyte-macrophage colony-stimulating factor in the sera of Schistosoma japonicum-infected mice.

Authors:  M Owhashi; Y Nawa
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.